Chronic cough, a prevalent and often vexing condition, poses significant diagnostic and therapeutic challenges for clinicians. This article aims to provide a comprehensive approach to diagnosing and managing chronic cough, with a focus on evidence-based practices and recent advances in the field.
Diagnosing chronic cough requires a systematic approach that involves a thorough patient history and physical examination. The clinician should consider common causes such as gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). However, less common etiologies like bronchogenic carcinoma or foreign body aspiration must also be considered. Diagnostic tools such as chest X-rays, spirometry, and bronchoscopy can facilitate the identification of the underlying cause.
Management of chronic cough should be tailored to the identified cause. For example, GERD-related cough may respond to proton pump inhibitors, while inhaled corticosteroids may be beneficial for cough variant asthma. For idiopathic chronic cough, recent studies suggest that speech therapy may be an effective intervention. It is also essential to reassess and adjust the treatment plan regularly based on the patient's response.
Recent advancements have led to the identification of novel cough biomarkers and the development of new antitussive drugs. For instance, P2X3 antagonists have shown promising results in clinical trials for refractory chronic cough. Additionally, the role of cough hypersensitivity syndrome in chronic cough is gaining recognition, opening new avenues for therapeutic interventions.
Chronic cough is a complex clinical entity that requires a comprehensive and individualized approach to diagnosis and management. Understanding the common and uncommon causes, employing a systematic diagnostic approach, and staying abreast of emerging trends can help clinicians effectively manage this challenging condition. Continuous research and innovation in this field promise to bring new insights and improved patient outcomes in the future.
1.
Health researchers discuss Medicaid cancer screening trends, best practices
2.
Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma
3.
Approved BTK Inhibitor Without Covalent Bond for CLL.
4.
Genomic Newborn Screening Could Identify Childhood Cancer Predisposition
5.
AI-based breast cancer risk technology receives FDA breakthrough device designation
1.
Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms
2.
Innovative Solutions in Hematology for Specialists
3.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
4.
Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy
5.
Evidence-Based Insights in Oncology for Specialists
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
2.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
3.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
5.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation